newsfilter
← Latest News
Business Wire·

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

  • Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) will present at the 2026 Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026, at 9:20 a.m. ET.
  • A webcast of the presentation will be available via the Investor Relations/Events section of Arcturus' website.
  • Arcturus is a San Diego-based mRNA medicines company founded in 2013, focusing on liver & respiratory rare disease therapeutics.
  • The company utilizes LUNAR® lipid-mediated delivery, STARR® mRNA technology, & mRNA manufacturing expertise.
  • Arcturus developed KOSTAIVE®, the first self-amplifying mRNA COVID vaccine approved globally.
  • Ongoing partnerships include a collaboration with CSL Seqirus & U.S. BARDA for pandemic flu, plus a Japanese joint venture named ARCALIS.
  • The pipeline includes RNA therapeutic candidates for cystic fibrosis & ornithine transcarbamylase deficiency, along with partnered vaccine programs for SARS-CoV-2 & influenza.
  • Arcturus possesses a patent portfolio covering over 500 patents & patent applications across the U.S., Europe, Japan, China, & other countries.
  • Contact for investor & public relations inquiries is Neda Safarzadeh, VP, Head of IR/PR/Marketing, at IR@ArcturusRx.com or (858) 900-2682.